• 免費註冊
  • 加入官方line@
  • 加入FB粉絲團

台股 » 個股 » 太景*-KY » 籌碼相關 » 券商分點績效 » 券商分點個股進出

太景*-KY

(4157)
可現股當沖
  • 股價
    10.80
  • 漲跌
    ▼0.05
  • 漲幅
    -0.46%
  • 成交量
    438張
  • 產業
    上櫃 生技醫療類股

  • 265人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
太景*-KY (4157)籌碼相關－台中銀-員林 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效，來找出真正獲利的贏家所在券商分點，進而追蹤此贏家所操作的股票與軌跡。

股票投資新手教室：一秒知道是否上對大戶列車

台中銀-員林 券商分點個股進出

台中銀-員林 券商分點全部個股操作績效/獲利分析

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/22210.8500.0010.8021,2210.16%
2024/12/2000.00111.0010.90-11,109-0.09%
2024/12/170.411.3000.0011.250.41,1100.04%
2024/12/11111.8000.0011.8511,1060.09%
2024/12/06212.0000.0012.0021,1220.18%
2024/12/0500.00212.2012.05-21,117-0.18%
2024/11/26512.3000.0012.3051,1330.44%
2024/11/20112.5000.0012.4519280.11%
2024/11/144.112.4500.0012.204.19320.44%
2024/11/080.313.7400.0013.700.38570.03%
2024/11/0100.00413.9014.10-41,020-0.39%
2024/10/2900.00214.1013.95-21,025-0.20%
2024/10/14114.2500.0014.2511,1340.09%
2024/10/111.414.3600.0014.301.41,1590.12%
2024/10/09114.4500.0014.4011,1730.09%
2024/10/0100.00115.1015.10-11,323-0.08%
2024/09/2500.00414.6014.75-41,306-0.31%
2024/09/160.214.4000.0014.400.21,3930.01%
2024/09/04313.93113.9513.9521,6290.12%
2024/08/2900.00214.5514.40-21,760-0.11%
2024/08/2200.00214.5014.40-21,828-0.11%
2024/08/2000.00214.6514.80-21,841-0.11%
2024/08/1900.003014.7514.70-301,819-1.65%
2024/08/15114.6000.0014.4511,8270.05%
2024/08/07113.55314.0714.05-21,896-0.11%
2024/07/2900.00314.1514.05-31,911-0.16%
2024/07/122014.7500.0014.65202,8230.71%
2024/07/10214.5000.0014.4522,8290.07%
2024/07/08314.97215.1514.9012,7480.04%
2024/07/05115.10115.1515.1002,7130.00%
2024/07/03215.0800.0015.0522,7010.07%
2024/07/02215.0300.0015.0522,7010.07%
2024/07/01315.1000.0015.1032,7120.11%
2024/06/2700.00415.2515.25-42,726-0.15%
2024/06/2600.00415.2315.25-42,722-0.15%
2024/06/25215.0500.0015.0522,7140.07%
2024/06/2400.002.115.2515.10-2.12,745-0.07%
2024/06/21115.0500.0015.1512,7690.04%
2024/06/2000.000.115.2015.10-0.12,8250.00%
2024/06/192.215.08215.0515.050.22,8230.01%
2024/06/18115.1000.0015.1012,8200.04%
2024/06/170.215.10315.2515.35-2.82,814-0.10%
2024/06/143015.0800.0015.05302,7921.07%
2024/06/13815.1400.0015.0082,7730.29%
2024/06/124.315.4900.0015.304.32,7340.16%
2024/06/111.215.80115.7015.550.22,7060.01%
2024/06/07415.53115.7015.4032,6490.11%
2024/06/06515.6500.0015.4052,6090.19%
2024/06/05115.3000.0015.4012,5760.04%
2024/05/3000.00215.4815.35-22,621-0.08%
2024/05/28115.1000.0015.0512,6160.04%
2024/05/24415.03415.0515.0502,6170.00%
2024/05/23115.2000.0015.2012,6160.04%
2024/05/17415.51815.5815.55-42,580-0.15%
2024/05/16215.05115.1515.1012,5570.04%
2024/05/1500.00215.0515.05-22,574-0.08%
2024/05/14115.05115.0015.0002,5750.00%
2024/05/09515.35315.4315.3522,5400.08%
2024/05/08115.0500.0014.9512,4950.04%
2024/05/03415.1100.0015.0042,4780.16%
2024/04/26515.56315.4015.4022,3700.08%
2024/04/2500.00315.5515.50-32,345-0.13%
2024/04/24115.5000.0015.4512,3260.04%
2024/04/23115.70115.9015.5002,2950.00%
2024/04/22216.0300.0015.6022,2470.09%
2024/04/1923.917.03817.1516.4515.92,0410.78%
2024/04/1800.001215.7515.75-121,621-0.74%
2024/04/17214.3800.0014.3521,4510.14%
2024/04/16114.2500.0014.2511,4490.07%
2024/04/0900.00115.3015.20-11,433-0.07%
2024/04/08115.3500.0015.3011,4310.07%
2024/03/2600.00115.5015.35-11,298-0.08%
2024/03/2500.00215.5515.40-21,273-0.16%
2024/03/12115.0000.0014.9011,2670.08%
2024/03/0800.000.114.7014.55-0.11,335-0.01%
2024/03/07014.7000.0014.7501,4920.00%
2024/03/06014.7500.0014.7001,5690.00%
2024/03/050.115.0000.0014.800.11,5770.01%
2024/02/22015.5000.0015.2501,8640.00%
2024/02/2100.00115.7015.65-11,849-0.05%
2024/02/2000.00515.4515.55-51,837-0.27%
2024/02/1900.00215.8015.50-21,835-0.11%
2024/02/1600.00115.4015.40-11,803-0.06%
太景抗流感病毒新藥 正式向中國藥監局申請上市許可UDN聯合新聞網－2024/08/04
太景*-KY（4157）4日晚間公告，接獲合作夥伴健康元藥業集團通知，太景開發的抗流感病毒新藥Pixavir (TG-1......詳全文
太景*-KY流感抗病毒新藥三期臨床 提前完成收案750人Anue鉅亨－2024/01/08
...詳全文
太景新藥 取得俄國藥證UDN聯合新聞網－2022/08/29
太景*-KY （4157）昨（28）日代子公司太景生技公告，抗生素新藥奈諾沙星靜脈輸液（500 mg/250 ml）已獲......詳全文
太景*-KY 相關文章